Daiichi Sankyo, Takeda to Join in Distribution of Kaketsuken’s Seasonal Influenza Vaccine “to Bolster Stable Supplies”

The Chemo-Sero-Therapeutic Research Institute (Kaketsuken), Daiichi Sankyo, and Takeda Pharmaceutical announced on May 19 a distribution agreement for Kaketsuken’s seasonal influenza vaccine Influenza HA Vaccine “Kaketsuken”. Up to now, this vaccine has been distributed exclusively by Astellas Pharma, but from...read more